Pioneering DNA synthesis company – inventor of the Gibson Assembly method and the BioXp system – furthers its mission to empower researchers in moving from reading DNA to writing and printing DNA SAN DIEGO, California SGI-DNA, Inc. creators of the world’s first fully automated system for high-throughput writing of DNA, the BioXp 3200 system, today […]
The international consortium, together with the AIRR Community, is now in the process of mapping the different initiatives producing data in the context of Coronavirus, to facilitate sharing data with laboratories and health institutions. RAMAT GAN, Israel – The international iReceptor Plus consortium is offering the technology tools and infrastructure developed within the EU-funded project, to […]
New arrayed B cell CRISPR knockout screening service strengthens support for development of therapeutics for diseases involving the immune system First in the market, this unique service complements the Company’s T cell screening service Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing […]
DUBLIN, Ireland, and MILAN, Italy: ERS Genomics Limited (“ERS Genomics”), which was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Axxam S.p.A. (“Axxam”), a leading discovery biology company, today announced the signing of a license agreement granting Axxam access to ERS Genomics’ CRISPR-Cas9 patent portfolio, to support […]
Back in September 2018, LGC acquired Lucigen Corporation. The ISO accredited site is based in Middleton, Wisconsin and employs just over 75 people. Lucigen specialises in enzymes, competent cells, and cloning systems to support applications in diagnostics, drug discovery, synthetic biology and gene editing, and now as a part of the Biosearch Technologies portfolio, is expanding […]
Expansion of marketing team to drive commercial launch of LX Genetic Analyzer BEVERLY, Mass. – LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, today announced the appointment of Dr. Eleanor Kolossovski to the role of Director of Product Marketing. Dr. […]
Specially developed research-grade PepTivator® Peptide Pools for SARS-CoV-2 BERGISCH GLADBACH – Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19. Based on decades worth of experience in developing products for virus-specific T cell research, SARS-CoV-2 PepTivator Peptide Pools work by stimulating […]
Bionano Genomics, Rescale, Amazon Web Services, and Genoox are donating consumables and compute resources to this effort based in Hannover, Germany SAN DIEGO – Bionano Genomics, Inc. (BNGO) announced today the launch of the largest study to date aiming to identify genomic variants and novel active substances that influence resistance or sensitivity to the SARS-CoV2 […]
Micro-RNA compound found suitable for further development following favorable pharmacokinetic and pharmacodynamic study results Cambridge, UK, and Budapest, Hungary Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, and Pharmahungary Group, a preclinical and clinical R&D […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) announced today the launch of the largest study to date aiming to identify genomic variants and novel active substances that influence resistance or sensitivity to the SARS-CoV2 virus, or COVID-19, disease progression and drug response. A variety of genomic and other biological variables will be compared between […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
